Newstral
Eli Lilly
- Daily Battle To Find Drugs Amid Shortages, England’s Pharmacists SayForbes
- AlphaFold 3 unlocks a new scientific era, mastering 'all of life's molecules'newatlas.com
- Google DeepMind’s Groundbreaking AI for Protein Structure Can Now Model DNAWired.com
- TAnalyse: Wann auch Wachstumsaktien vernünftig bewertet sein könnenthemarket.ch
- News24 | FNB provides JSE access to Nvidia, Eli Lilly and Booking.com ownerNews24
- Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug FrenzyForbes
- Can biotech startups upstage Eli Lilly and Novo Nordisk?The Economist
- Wall Street’s ugly April gets even worse as it tumbles across the finish lineLA Times
- Dow tumbles over 400 points as investors on edge ahead of Fed rate decisionNew York Post
- FEli Lilly lifts guidance on strong sales of diabetes and weight loss drugsft.com
- CKris Jenner stuns in oversized cape at LA gallery after weight loss scare – stylish and confidentcentralrecorder.com
- A 3x Expected Rise In Mounjaro Sales Is Likely To Drive Eli Lilly’s Q1Forbes
- TikTok cracks down on social media influencers pushing Ozempic, Wegovy while facing potential US banNew York Post
- News24 | SA can help ease global shortage of blockbuster weight-loss medication, says AspenNews24
- Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cutSeattle Times
- Sleep apnea reduced in people who took weight-loss drug, Eli Lilly reportsThe New York Times
- Wall Street holds a bit steadier as pressure eases from the bond marketmecktimes.com
- Eli Lilly & Co: Eli Lilly weight-loss drug found to address sleep apnoea in trialFinancial Times
- Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker saysSan Jose Mercury News
- NHollywood’s Ozempic Epidemicnewsweek.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.